What Kind of Drug is Savolitinib?

Savolitinib is a targeted therapy drug primarily indicated for the treatment of patients with locally advanced or metastatic solid tumors (e.g., non-small cell lung cancer [NSCLC]) harboring MET gene abnormalities.